Immunobiochemical indices in clinically healthy horses and horses with equine infectious anemia
Abstract
Aim. Equine infectious anemia (EIA) remains an urgent problem for many countries. This article presents the initial comprehensive comparative analysis of the immunobiochemical profiles of clinically healthy horses and those afflicted with the EIA in the western region of Ukraine. To address this objective, the immunobiochemical indices in healthy horses in the western region of Ukraine, the seasonal and age-related dynamics of the content of circulating immune complexes (CIC), vitamin C, and lysozyme were investigated. A possible association between the increase in the CIC rate and the content of serum fractions of protein and immunocompetent cells in horses with asymptomatic EIA course was determined. Methods. The study encompassed 329 non-purebred male and female horses of various age groups, comprising 225 EIA-free horses and 104 horses with asymptomatic EIA. Common serological and bio- chemical methods were employed, and identification of horses with EIA was accomplished via agar gel immunodiffu- sion assay with diffuse precipitation. Results. The aspects of changes in the immunobiochemical status of the animals in terms of age and season were determined. The findings demonstrated that with the increase in CIC in the serum of healthy animals, there was an increase in the amount of total protein, albumins, α-globulins, γ-globulins, and the number of О-cells and subpopulations of Тr- and Тs-lymphocytes. The number of β-globulins and immunocompetent cells of Т- and В-lymphocytes diminished. The animals with the asymptomatic EIA course demonstrated a reliable decrease in the fraction of albumins (р < 0.05), β-globulins (р < 0.05), and the increase in the fraction of γ-globulins (р < 0.05). In spring, healthy four-year-old and older horses had a considerable increase in the CIC rate (30.4–90.6 c.u.) as compared to other seasons (33.4–63.6 c.u.), which demonstrated the accumulation of antigen-antibody com- plexes in the organism during this period. Generally, the analysis showed that the older the horses were, the clearer the tendency towards higher CIC rate was, and the smaller the content of vitamin C with age, except for the group of 10-year-old and older horses where it was slightly increased, and there was the decrease in the lysozyme activity with age. The content of heterohemagglutinins in healthy horses increased from 6.25 to 12.02 c.u. with age, and in horses with the asymptomatic EIA course there was a decrease from 10.6 c.u. in 3-year-old horses to 6.26 in 4–9-year-old horses, and a slight increase up to 8.07 when horses were ten or more years old. The study of the seasonal state of non-specific factors of protection and humoral immunity in the selected group of horses with EIA demonstrated that the CIC rate in healthy and infected horses changed dynamically depending on the season – it was higher in spring and lower in all the other seasons. The maximal rate of CIC in infected horses was in spring (90.62 c.u.), and the minimal one – in summer (52.73 c.u.). The titer of specific antibodies to the EIA virus did not change considerably in different seasons. Conclusions. The study determined that a high CIC rate in the blood of horses with asymptomatic EIA indi- cated substantial alterations in their immunobiological status. The elevation in the rate of isoantibodies in horses with asymptomatic EIA, as compared to the healthy animals, highlighted the development of the autoimmune process in EIA-afflicted horses. This phenomenon occurred concurrently with an increase in other non-specific antibodies, contributing to an overall rise in CIC levels, while the levels of specific antibodies remained relatively stable. This study represents the first simultaneous investigation of both specific immunity (CIC) and non-specific immunity (lysozyme activity, content of vitamin C, protein fractions of blood, etc.) in the context of EIA.References
A code of practice for equine infectious anaemia. DARD 4 August 2006. http://www.dardni.gov.uk/code-of-practice-for-equine-infectious-anaemia.pdf. revised 19/08/2015
Busol VA, Mandygra MS, Galatiuk OE et al (1996) Methodological recommendations for the evaluation of the immune status of horses in the normal state and in the hidden course of infectious anemia. Rivne. (In Ukrainian)
Cheevers WP, McGuire TC (1985) Equine infectious anemia virus: immunopathogenesis and persistence. Rev Infect Dis 7(1):83–88. https://doi.org/10.1093/clinids/7.1.83. PMID: 2984759.
Clabough DL, Gebhard D, Flaherty MT et al (1991) Immune-mediated thrombocytopenia in horses infected with equine infectious anemia virus. J Virol 65(11):6242–6251. https://doi.org/10.1128/JVI.65.11.6242-6251.1991
Coggins L, Norcross NL, Nusbaum SR (1972) Diagnosis of equine infectious anemia by immunodiffusion test. Am J Vet Res 33(1):11–18. PMID: 4333633.
Chumachenko VE, Vysotsky AM, Serdyuk NA, Chumachenko VV (1990) Determination of natural resistance and metabolism in farm animals. Kyiv. (In Russian). 136 p.
Equine infectious anaemia. OIE Terrestrial Manual (2019). https://www.woah.org/fileadmin/Home/fr/Health_standards/tahm/3.05.06_EIA.pdf
Gołda R, Krumrych W, Danek J (2014) Analysis of circulating immune complexes in the serum of clinically healthy horses. J Equine Veterinary Sci 34(8):963–966. https://doi.org/10.1016/j.jevs.2014.04.009
Grinevich YuA, Kamenets LYa (1986) Fundamentals of clinical immunology of tumors. Kyiv. (In Ukrainian). 160 p.
Henson JB, McGuire TC (1971) Immunopathology of equine infectious anemia. Am J Clin Pathol 56(3):306–313. https://doi.org/10.1093/ajcp/56.3.306
Hussain KA, Issel CJ, Schnorr KL et al (1987) Antigenic analysis of equine infectious anemia virus (EIAV) variants by using monoclonal antibodies: epitopes of glycoprotein gp90 of EIAV stimulate neutralizing antibodies. J Virol 61(10):2956–2961. https://doi.org/10.1128/JVI.61.10.2956-2961.1987
Informe Comisión Europea RASVE: Alertas y Notificaciones. 1er cuatrimestre; 2012.
Ishizaki R, Green RW, Bolognesi DP (1978) The structural polypeptides of equine infectious anemia virus. Intervirology 9(5):286–294. https://doi.org/10.1159/000148946
Kemen MJ, Coggins L (1972) Equine infectious anemia: transmission from infected mares to foals. J Am Vet Med Assoc 161(5):496–499. PMID: 4626365
Kono Y, Hirasawa K, Fukunaga Y, Taniguchi T (1976) Recrudescence of equine infectious anemia by treatment with immunosuppressive drugs. Natl Inst Anim Health Q (Tokyo) 16(1):8–15. PMID: 177894.
Leroux C, Cadoré J-L, Montelaro R (2004) Equine Infectious Anemia Virus (EIAV): what has HIV’s country cousin got to tell us? Veterinary Research 35(4):485–512. https://doi.org/10.1051/vetres:2004020
Malik P, Singha H, Sarkar S (2017) Equine Infectious Anemia. In: Bayry, J. (eds) Emerging and Re-emerging Infectious Diseases of Livestock. Springer, Cham. https://doi.org/10.1007/978-3-319-47426-7_8
Mandyhra MS, Rudʹ OH (2001) Hematological and immunological indicators in cattle at different stages of the leukemic process. Veterinary medicine: Interdepartmental thematic scientific collection. 79(1.2):18–22. (In Ukrainian)
Maslianko RP (2007) Guidelines on the assessment and monitoring of the immune status of the animals. Lviv. (In Ukrainian)
McGuire TC, Crawford TB, Henson JB (1972) Equine infectious anemia: detection of infections virus-antibody complexes in the serum. Immunol Commun 1(6):545–551. https://doi.org/10.3109/08820137209022963
Morales BA, Méndez SA, Morales BM (2015) Anemia Infecciosa Equina, una revisión. Rev Inst Nac Hig “Rafael Rangel” 46(1–2):64–74. http://ve.scielo.org/pdf/inhrr/v46n1-2/art08.pdf
Murray RK, Granner DK, Mayes PA et al (1998) Harper’s Biochemistry. Prentice-Hall Int. Inc., 1014 p
Payne SL, Rushlow K, Dhruva BR et al (1989) Localization of conserved and variable antigenic domains of equine infectious anemia virus envelope glycoproteins using recombinant env-encoded protein fragments produced in Escherichia coli. Virology 172(2):609–615. https://doi.org/10.1016/0042-6822(89)90203-1
Perryman LE, O’Rourke KI, McGuire TC (1988) Immune responses are required to terminate viremia in equine infectious anemia lentivirus infection. J Virol 62(8):3073–3076. https://doi.org/10.1128/jvi.62.8.3073-3076.1988
Popova L, Polikarpova A (2012) Biochemistry. Kharkiv: KNMU, 540 p. (In Ukrainian)
Skards IV (1968) Activation of leukocytes [Aktivatsiya leykotsitov]. Riga: Zinatne. (In Russian). 158 p
Scicluna MT, Issel CJ, Cook FR et al (2013) Is a diagnostic system based exclusively on agar gel immunodiffusion adequate for controlling the spread of equine infectious anaemia? Vet Microbiol 165(1–2):123–134. https://doi.org/10.1016/j.vetmic.2013.02.027
Sellon DC, Perry ST, Coggins L (1992) Wild-type equine infectious anemia virus replicates in vivo predominantly in tissue macrophages, not in peripheral blood monocytes. J Virol 66:5906. https://doi.org/10.1128/JVI.66.10.5906-5913.1992
Sellon DC (1993) Equine Infectious Anemia. Veterinary Clinics of North America: Equine Practice 9(2):321–336. https://doi.org/10.1016/S0749-0739(17)30399-1
Sentsui H, Kono Y (1976) Hemagglutination by equine infectious anemia virus. Infect Immun 14(2):325–331. https://doi.org/10.1128/iai.14.2.325-331.1976
Vlizlo VV, Fedoruk RS, Ratich IB et al (2012) Laboratory methods of research in biology, animal husbandry and veterinary medicine: handbook. Lviv: SPOLOM. (In Ukrainian)
Equine Infectious Anemia Report 2022. https://www.aphis.usda.gov/animal_health/downloads/animal_diseases/2022-eia-report.pdf

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.


